Drreddys Laboratories | RDY - Sales Revenues


Drreddys Laboratories reported INR87.27B in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
ANI Pharmaceuticals USD 247.06M 19.25M Dec/2025
Aurora Cannabis CAD 90.37M 7.65M Sep/2025
Bayer EUR 11.44B 1.78B Dec/2025
Canopy Growth CAD 66.68M 5.45M Sep/2025
Cipla INR 75.18B 710M Dec/2025
Corcept Therapeutics USD 202.12M 5.48M Dec/2025
Drreddys Laboratories INR 87.27B 1.82B Dec/2025
GlaxoSmithKline GBP 8.62B 73M Dec/2025
Hikma Pharmaceutical USD 1.69B 863M Dec/2025
Lonza CHF 3.58B 63M Jun/2025
Novartis USD 13.91B 144M Sep/2025
Pacira USD 196.87M 17.35M Dec/2025
Phibro Animal Health USD 373.91M 10.02M Dec/2025
Prestige Brands USD 283.44M 9.34M Dec/2025
Richter Gedeon HUF 214.69B 26.79B Sep/2025
Sun Pharmaceuticals INR 147.99B 3.21B Dec/2025
Supernus Pharmaceuticals USD 211.6M 19.5M Dec/2025
Teva Pharmaceutical Industries USD 14.63B 10M Dec/2025